Biomarker Discovery & Validation

The utilization of Biomarkers in medication improvement has clinical advantages that lie in assessing helpful reaction or in observing and diagnosing the action of illnesses. The disclosure and approval Biomarkers fill in as new surrogate endpoints in starting phase of medication preliminaries. The parts of the biomarker improvement process incorporate capability, revelation, check, explore examine streamlining, commercialization and clinical approval. For improvement and disclosure of biomarker omics procedures like metabolomics, Transcriptomics, proteomics, and genomics are utilized and for approval of Biomarkers computational science, profiling strategies, information mining techniques and microarray information investigation can be used.

  • Biomarkers and endpoints for pain
  • Advancements in the technologies for discovery of biomarkers
  • identification and initial biological, analytical and clinical validation of pain biomarkers
  • New strategies for discovery and validation of biomarkers.

Related Conference of Biomarker Discovery & Validation

March 18-19, 2024

5th Global Summit on Oncology and Hematology

Zurich, Switzerland
June 10-11, 2024

8th Global Meeting on Oncology and Radiology

Barcelona, Spain
July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France

Biomarker Discovery & Validation Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in